SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-028281
Filing Date
2023-06-15
Accepted
2023-06-15 16:07:42
Documents
12
Period of Report
2023-06-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K lyra-20230613.htm   iXBRL 8-K 68985
  Complete submission text file 0000950170-23-028281.txt   186643

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyra-20230613.xsd EX-101.SCH 2481
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyra-20230613_lab.xml EX-101.LAB 13350
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyra-20230613_pre.xml EX-101.PRE 9848
6 EXTRACTED XBRL INSTANCE DOCUMENT lyra-20230613_htm.xml XML 4698
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 231017391
SIC: 3841 Surgical & Medical Instruments & Apparatus